General Acute Care Hospital · Greenbrae, CA
NPI
1295980431
Since 2008
Specialty
General Acute Care Hospital
Code 282N00000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
250 Bon Air Rd,, Marin General Hospital
Greenbrae, CA, 94904
Phone (510) 230-3320
Groups this clinician bills Medicare through
Medicare paid, 2024
$311K
6,094 services
Medicare patients, 2024
367
Average age 79
Drug cost, 2024
$595K
6,098 prescriptions
Company payments, 2025
$1,292
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Azita Taghavy was code J0897 (injection, denosumab, 1 mg), 3,360 times for 31 patients. In total Azita Taghavy billed 6,094 services in 25 codes, and Medicare paid $311K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-10-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 3,360 | 31 | $20.49 | $69K |
| 99214 Office E&M - Established | Office | 910 | 312 | $122.65 | $112K |
| 99213 Office E&M - Established | Office | 681 | 287 | $72.32 | $49K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 262 | 262 | $157.83 | $41K |
| 93000 Electrocardiogram | Office | 228 | 216 | $12.47 | $2,844 |
| 99442 Telephone Services | Office | 138 | 95 | $77.31 | $11K |
| 96372 Injection Administration | Office | 103 | 44 | $13.43 | $1,384 |
| 90653 Vaccine Product | Office | 94 | 91 | $81.82 | $7,691 |
| G0008 Administration of influenza virus vaccine | Office | 94 | 91 | $38.72 | $3,640 |
| 99441 Telephone Services | Office | 78 | 61 | $49.27 | $3,843 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 45 | 11 | $0.96 | $43.26 |
| 99212 Office E&M - Established | Office | 29 | 27 | $38.41 | $1,114 |
| 99205 Office E&M - New | Office | 20 | 20 | $190.30 | $3,806 |
By year: 2022 $279K for 7,437 services; 2023 $255K for 6,728 services; 2024 $311K for 6,094 services.
Medicare prescription drug claims, 2024
In 2024, the drug Azita Taghavy prescribed most often to Medicare patients was Atorvastatin Calcium, with 332 prescriptions and refills. In total Azita Taghavy wrote 6,098 Medicare prescriptions that cost $595K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 332 | 964 | 96 | $3,984 |
| Levothyroxine Sodium Generic | 329 | 935 | 87 | $6,504 |
| Rosuvastatin Calcium Generic | 246 | 711 | 69 | $4,231 |
| Losartan Potassium Generic | 235 | 672 | 70 | $2,841 |
| Amlodipine Besylate Generic | 168 | 480 | 56 | $1,295 |
| Gabapentin Generic | 146 | 267 | 44 | $2,349 |
| Ezetimibe Generic | 117 | 308 | 31 | $3,140 |
| Escitalopram Oxalate Generic | 96 | 215 | 25 | $1,808 |
| Metoprolol Succinate Generic | 96 | 270 | 29 | $1,870 |
| Alprazolam Generic | 96 | 120 | 19 | $720 |
| Tamsulosin Hcl Generic | 94 | 238 | 25 | $1,161 |
| Azithromycin Generic | 85 | 85 | 75 | $447 |
| Lisinopril Generic | 82 | 237 | 26 | $744 |
| Metformin Hcl Er Metformin Hcl | 79 | 223 | 34 | $955 |
| Omeprazole Generic | 79 | 189 | 22 | $1,292 |
Brand drugs: 797 claims; generic drugs: 5,260 claims; opioid claims: 275.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Azita Taghavy $1,292 ($1,292 in general payments such as food, travel and fees) from 13 companies. The largest payer was Novo Nordisk Inc with $242.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 7 | $242 |
| Pfizer Inc. PFE | 8 | $184 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $152 |
| Abbvie Inc. ABBV | 7 | $146 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $118 |
| Lilly USA, LLC LLY | 3 | $94.1 |
| Astellas Pharma US Inc 4503.T | 3 | $84.13 |
| Sanofi Pasteur Inc. SNY | 2 | $70.11 |
| Amgen Inc. AMGN | 2 | $67.05 |
| Amneal Pharmaceuticals LLC AMRX | 2 | $48.13 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.